Commence

Boehringer Ingelheim to Commence Phase III Study Investigating the Role of BIBW 2992 as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Mutations

RIDGEFIELD, Conn., Aug. 3 /PRNewswire/ -- Boehringer Ingelheim announced today at the International Association for the Study of Lung Cancer's 13th World Conference on Lung Cancer (WCLC), San Francisco, CA, the initiation of a Phase III clinical study of BIBW 2992 as first-line treatment...

Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack

- SYNCHRONY Study Published in The Lancet Supports Cardio-Protective Potential of Aleglitazar - NUTLEY, N.J., June 9 /PRNewswire/ -- Roche today announced it will start Phase III clinical investigations for aleglitazar, its innovative PPAR co-agonist R1439 which is uniquely designed to reduce...

Haiti Hosts Opening Ceremony of the 2009 International AIDS Candlelight Memorial: Worldwide Events Commence With the Announcement of a National HIV Testing Campaign in Haiti

PORT-AU-PRINCE, Haiti, May 16 /PRNewswire-USNewswire/ -- The opening ceremony of the International AIDS Candlelight Memorial was held tonight in Haiti, kicking off over 1,000 Candlelight events in more than 100 countries as part of the world's oldest and largest HIV/AIDS grassroots mobilization ev...

FDA Grants Ethicon Endo-Surgery Approval of Its IDE Application to Commence Study of Notes Toolbox(TM)

CINCINNATI, April 22 /PRNewswire/ -- Ethicon Endo-Surgery today announced that the U.S. Food and Drug Administration (FDA) granted approval of the company's Investigational Device Exemption (IDE) application to conduct the first study of devices designed for use in natural orifice translumen...

Abbott to Commence Tender Offer on Jan. 27 for All Outstanding Shares of Advanced Medical Optics, Inc.

ABBOTT PARK, Ill., Jan. 26 /PRNewswire-FirstCall/ -- Abbott ( NYSE: ABT ) will commence tomorrow, Tuesday, Jan. 27, 2009, a cash tender offer for all outstanding shares of common stock of Advanced Medical Optics, Inc. (AMO) for $22 per share. The tender offer will be made pursuant to the terms ...

QLT to repurchase up to US$ 50 million of common shares - Modified "Dutch Auction" tender offer to commence on or about December 4, 2008

Range of $2.20 to $2.50 per share represents a premium of 16% to 32% from previous day's closing price VANCOUVER, Dec. 1 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI ; TSX: QLT) announced that its Board of Directors has authorized management to proceed with a modified "Dutc...

Algeta Receives IND Approval for Alpharadin(TM) to Commence Clinical Development in the USA

OSLO, February 21 /PRNewswire-FirstCall/ -- Algeta ASA (OSE: ALGETA), the cancer therapeutics company, today announced that it will shortly commence clinical development of Alpharadin(TM) in HRPC patients in the USA. Algeta filed its Investigational New Drug (IND) application for its lead prod...

Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study

MEMPHIS, Tenn., Nov. 12 /PRNewswire/ -- Northwestern University announced today that it has begun enrollment for a national clinical research study for women with locally recurrent or metastatic breast cancer. The Northwestern trial will evaluate the efficacy of Nexavar(R) (sorafenib) tablets ...

Endocare Stock to Commence Trading on NASDAQ

IRVINE, Calif., Oct. 9 /PRNewswire-FirstCall/ -- Endocare, Inc. (OTC Bulletin Board: ECRE), an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, announced today that it has been approved for listing on NASDAQ. The Com...

Dubai to commence free breast cancer screening

Dubai: With a motive of enabling women the best possible avenues to maintain good health, the UAE is about to commence a free breast cancer screening// in Dubai, scheduled to begin next month. The tests will enable all women in the emirate, UAE nationals, expatriates and visitors, to avail t...

More>>

Commence in Medical Technology

BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes

WOBURN, Mass., Aug. 20 /PRNewswire/ -- BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, today announced the UK Medicines and Healthcare products Regulatory Agency (MHRA) has accepted BioVex's Clinical Trial Applicatio...

Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial

LONDON, July 30 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN), a leading European RNAi focused biotechnology company, today announces that its partner, Quark Pharmaceuticals Inc. ("Quark") together with Pfizer, has commenced a Phase II clinical trial with RTP-801i-14 (PF-4523655), a smal...

Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia

BETHESDA and GAITHERSBURG, Md., June 12 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ) and MedImmune announced today that the first patient has started treatment in a multi-center, phase 2 trial conducted in Germany investigating BiTE(R) antibody blinatumomab (MT103/MEDI-538) in pat...

Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis

LONDON, June 11 /PRNewswire/ -- Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on the development of novel anti-inflammatory drugs, today announced that it has obtained regulatory approval from the South African Medicines Control Council (MCC) to initiate a Phase II study o...

PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.

FRANKLIN, Mass., March 20 /PRNewswire-FirstCall/ -- PLC Systems Inc. (Amex: PLC ) announced today that it has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin enrollment in a U.S. pivotal trial to study the effectiveness of the Company's RenalGuard Thera...

Nestle Nutrition and Phosphagenics to Commence Phospha E(R) Phase 2 Clinical Trial

MELBOURNE, Australia, Oct. 4 /PRNewswire-FirstCall/ -- Phosphagenics Limited (ASX: POH, AIM: PSG, OTCQX: PPGNY) and Nestle Nutrition (Nestle) today announced that they will jointly commence a phase 2 human clinical trial in Australia to establish the efficacy of Phosphagenics' Phospha E(R) in ...

Phosphagenics to Commence Phase 2 TPM/Insulin Clinical Trial

MELBOURNE, Australia, Sept. 12 /PRNewswire-FirstCall/ -- Phosphagenics Limited (ASX: POH, AIM: PSG, OTCQX: PPGNY) today announced that it has received approval to commence a Phase 2 clinical trial of its proprietary transdermal insulin, TPM/Insulin. The Phase 2 trial, to commence this month, ...

LANI completes Phase I in Japan and to commence Phase I in UK

Melbourne, Australia — 19 April 2007- Biota Holdings Limited (ASX:BTA) today announced that its long acting neuraminidase inhibitor (LANI), CS8958, an anti-influenza treatment, has: 1. demonstrated effectiveness against the avian flu virus H5N1; 2. completed Phase I studies in Japan; and...

Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical Trial in Second Quarter

MELBOURNE, Australia, May 03, 2007 /PRNewswire-FirstCall/ -- Phosphagenics Limited (AIM: PSG) announced today that the Company intends to initiate a Phase 1b clinical trial to demonstrate the efficacy and safety of the improved formulation of its transdermal insulin product, TPM-02/Insulin, contai...

Medigus and Tower Semiconductor Announce World's Smallest Medical Video Camera Based on Advanced CMOS Image Sensor

...iagnostic and surgical medical applications. First product samples have been shipped to end customers and mass production of the camera is expected to commence in mid-2010. The camera sensor will be manufactured in Tower's Fab2 using its 0.18-micron CMOS image sensor process and will be integrated into the ca...

Commence in Medical Dictionary

Blackout

...ut (2007/III) ... ... who terrorize apartment dwellers during New York's 1977 power blackout . ... Black-Out à New York (France) Et la terreur commence (France) New York Blackout ... The massive Blackout has been described as the "hound" of Megatron. ... The name or term Bla...

Commence in Biological News

Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer

... completion of the confirmation process. Payment for the shares accepted for purchase, and return of all other shares tendered and not purchased, will commence promptly thereafter. Georgeson Securities Corporation is acting as the dealer manager for the tender offer and the information agent is Georgeso...

Gene therapy appears safe to regenerate gum tissue

...t step for the U-M team is to use the new gene delivery approach in human clinical trials, Giannobile said. The planning stages for these studies will commence in the next year. The paper, called "Adenovirus Encoding Human Platelet-Derived Growth Factor-B Delivered to Alveolar Bone Defects Exhibits Safety ...

Imperial College London and NTU collaborate to offer joint Ph.D. programs in engineering and science

...g and science. The NTU-Imperial College Joint PhD degree programme will commence with PhD programmes in Bioengineering and Chemical and Biomolecular Enginee...D student education. We are confident that this joint programme, which will commence with programmes under NTU's School of Chemical and Biomedical Engineering (...

New master switch found in the brain that regulates appetite and reproduction

...ls, it turns on TORC1, which, in turns activates CART to suppress appetite, because more food is not needed, and KISS1, signaling reproduction can now commence in this well-fed body. Conversely, when leptin is not activating brain receptors, TORC1 is turned off, as are CART and KISS1. They also discovered t...

Restoring Alabama's coast

...oject monitoring efforts. In early spring 2009, construction projects will commence at Boggy Point and Point aux Pins and seagrass planting will take place in Little Lagoon. Post-project monitoring will commence and continue until late summer 2011. The entire project is scheduled to be...

Digimarc Board Approves $310 Million All-Cash Offer from L-1 Identity Solutions for Digimarc's ID Systems Business

...able savings with more competitive pricing from economies of scale. Under the terms of the amended merger agreement, the tender offer is expected to commence on July 2, 2008, but no later than July 7, 2008 and remain open for 20 business days. The spin-off of the digital watermarking business will occur pri...

New fingerprint breakthrough by forensic scientists

...and Professor Rob Hillman of the Chemistry Department at the University now intend to take this research forward via a three-year Ph.D. studentship to commence next academic year. The new project will explore further the corrosion of metal by fingerprint residue and investigate how it might be used to detect ...

Court Approves Scheme of Arrangement

...ADSs on a one-for-one basis, each Shire Limited ADS representing three ordinary shares in Shire Limited. Dealings in Shire Limited ADSs on NASDAQ will commence at 9:30 a.m. (EST) on 23 May 2008. Immediately prior to the scheme becoming effective, Shire Limited will be substituted in place of Shire plc as pr...

Successful cooperation extends Dragon Program

...use of the countrys sheer size and various types of terrain, which range from Himalayan peaks to tropical lowlands. Dragon 2 EO data delivery will commence in May 2008 and continue for four years. ...

Oberthur Technologies XPon Offer

...ing 98.7% of the shares and votes in XPonCard. Settlement in respect of shares tendered during the extension of the acceptance period is expected to commence on or about 30 April 2008. The Offer will not be extended further. However, Oberthur may acquire additional shares in XPonCard in the market. As pre...

Commence in Biological Technology

D-Pharm Receives FDA Clearance to Commence a Phase III Trial of DP-b99 in Acute Stroke Patients

REHOVOT, Israel, June 8 /PRNewswire/ -- D-Pharm announced today that its Investigational New Drug (IND) application for a pivotal Phase III clinical trial of DP-b99 in acute ischemic stroke patients has been approved by the US Food and Drug Administration (FDA). D-Pharm plans to initiate the t...

Roche Intends to Commence Tender Offer to Acquire All Shares of Genentech for US$ 86.50 Per Share in Cash

BASEL, Switzerland, Jan. 30 /PRNewswire/ -- Roche announced today that it intends to commence a cash tender offer for all outstanding publicly-held shares of Genentech at US$ 86.50 per share. Roche, which currently owns 55.8% of the Genentech outstanding shares, expects to commence the tender offe...

Niusule Biotech Corp. to Commence Trading on the OTC Bulletin Board Under the Symbol 'NIUS'

CARSON CITY, Nev., Dec. 30 /PRNewswire-FirstCall/ -- Niusule Biotech Corp., a Nevada corporation formed on April 8, 2008, announced today that its shares of common stock will begin trading on the OTC Bulletin Board under the symbol "NIUS" on December 30th, 2008. For a NIUS quote, visit:...

Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today

Satisfies initial listing requirements with NASDAQ; Stock Symbol 'OGXI' Implements immediate restructuring program, which extends cash runway while focusing on clinical pipeline programs BOTHELL, WA, Aug. 21 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (formerly Sonus Pharmaceut...

Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014

VANCOUVER, July 7 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") (NASDAQ: ANPI , TSX: ANP), a global specialty pharmaceutical and medical device company, today announced the commencement of a cash tender offer of the outstanding notes listed below (the "Notes") in an a...

Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment

LONDON, January 10 /PRNewswire-FirstCall/ -- Amarin Corporation plc (NASDAQ: AMRN ) today announced that it has received the necessary regulatory and ethical approvals to commence a Phase IIa trial in Age Associated Memory Impairment (AAMI) with AMR101 (ultra-pure ethyl-EPA). The Phase IIa ...

FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208

New class of ApoA-I/HDL drugs to reverse atherosclerosis enters the clinic TSX Exchange Symbol: RVX CALGARY, Dec. 10 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that it has received approval by the US Food and Drug Administration (...

NeurogesX Reports Second Quarter 2009 Results

...ial commercial launch of Qutenza in the United States. In addition, we will commence activities to support Astellas to ensure a successful launch of Qutenza in Europe. We also plan to resume NGX-1998 development with the potential to commence significant activities in this program late this year or early next year. W...

Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients

...tates Food and Drug Administration (FDA), and patient dosing is expected to commence within the next several weeks. In the Phase II study, naive genotype...es to (i) Anadys' expectation that dosing in the ANA598 Phase II study will commence in the next several weeks; (ii) the ability for patients in the ANA598 Phas...

Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights

...acebo at each dose level. The study will be conducted at a number of clinical sites in the United States. Patient dosing in the trial is expected to commence in the next several weeks. Anadys expects to receive RVR data from the 200 mg dose group by year-end. Reported Potent Antiviral Activity/Good ...